Phase
Condition
Hyponatremia
Skin Wounds
Treatment
AGLE-102
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Eighteen years of age or older with deep second degree thermal burn wounds
Index burn injury within the prior 72 hours
Subjects must understand and be willing and able to give written informed consent
Subjects must agree to have blood draws performed per protocol
Subjects must be accessible for wound treatment and assessment visits
Males and females must agree to use an acceptable method of contraception.Exceptions will be females of non-childbearing age and monogamous males who arepartners of females of non-childbearing age. Acceptable methods of birth controlinclude; history of sterilization, oral contraceptives, depo-progesteroneinjections, a barrier contraceptive such as a condom with or without spermicidecream or gel, diaphragms or cervical cap with or without spermicide cream or gel, oran intrauterine device (IUD).
Maximum index wound size at screening limited to single or multiple wounds (in adefined anatomical area) cumulatively ≤ 600 cm2. Minimum wound size at screening: 30cm2. Other wounds may be present that are treated separately from this protocolsubject to the maximum TBSA exclusion criteria listed below.
Exclusion
Exclusion Criteria:
Solely first degree or solely third degree burns
Cumulative burn area ≥ 20% TBSA (20% TBSA corresponds to 3700 cm2 in a 70 kg, 175 cmsubject)
Burns that occur over a previous scar
Chemical, radiation, or electrical burns
Subjects with superficial second degree burn who are expected to heal within 2 weekswith standard therapy
Evidence of active infection at the wound site
Evidence of significant wound healing prior to treatment
Burn wounds requiring surgery (other than debridement), or skin grafting
Wound exclusively located in the area of fingers, toes, face, or perineum
Wound that extends > 50% across one or more joints
Have any requirement for the use of systemic steroids or immunosuppressivemedications
Subjects allergic to human albumin, streptomycin, or penicillin
Be a pregnant female or nursing mother
Subjects who are known or found to be HIV positive
History of alcohol or substance abuse requiring treatment within the past 12 months.
Severe medical conditions
Malignancy (other than non-melanoma skin cancer) not in remission or inremission less than 5 years
Life expectancy less than two years
Severe cardiopulmonary disease restricting ambulation to the clinical facility
WBC <3 or > 20 x109/L, Hgb < 9g/dL, platelet count 100x109/L or less, serumcreatinine > 1.5 times the upper normal limit, AST or ALT > 2.4 times upper normallimit
Known history of coagulopathy
Subjects who have a reasonable likelihood of being a recipient of tissue or organtransplantation
History of poor compliance, unreliability
Study Design
Study Description
Connect with a study center
Ron Manning
Miami, Florida 33136
United StatesActive - Recruiting
Ryder Trauma Center
Miami, Florida 33136
United StatesSite Not Available
North Carolina Jaycee Burn Center
Chapel Hill, North Carolina 27599
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.